VITREXTY

Welcome to the Brand page for “VITREXTY”, which is offered here for Pharmaceuticals in the nature of an injectable solution for intravitreal use  for the prevention of eye conditions including proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and retinitis pigmentosa;.

Its status is currently believed to be active. Its class is unavailable. “VITREXTY” is believed to be currently owned by “ALDEYRA THERAPEUTICS, INC.”

Owner:
ALDEYRA THERAPEUTICS, INC.
Owner Details
Description:
Pharmaceuticals in the nature of an injectable solution for intravitreal use  for the prevention of eye conditions including proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and retinitis pigmentosa;
Categories: PHARMACEUTICALS NATURE